Zhu Haiyan, Yu Xingmei, Hao Chuangli, Wang Yuqing, Yang Xiaoyun, Lu Yanhong, Sun Huiquan, Luo Wei, Lai Kefang
Department of Respiratory Diseases, Children's Hospital of Soochow University, Suzhou 215003, China.
Email:
Zhonghua Jie He He Hu Xi Za Zhi. 2015 May;38(5):352-5.
To determine the diagnostic value of fractional exhaled nitric oxide (FeNO) measurement in diagnosis of Cough Variant Asthma (CVA) in children.
Outpatients with a cough > 4 weeks visiting The Children's Hospital Affiliated to Suzhou University from March 2012 to April 2013 were enrolled. FeNO was measured by a nitric oxide analyzer in accordance with American Thoracic Society guidelines. The levels of FeNO in CVA and other causes of chronic cough were compared. The value of FeNO was assessed and the optimal operating point of FeNO testing for the diagnosis of CVA was determined by the means of the receiver operating characteristic (ROC) curves.
A total of 84 children with chronic cough were recruited, among whom 38 were diagnosed as having CVA. The levels of FeNO were not statistically different between patients with CVA [(37.2 ± 13.8) ppb] and patients with CVA combined with upper airway cough syndrome [UACS, (40.1 ± 13.8) ppb, P = 0.124], but were both significantly higher than those in patients with UACS or with postinfectious cough (PIC), and the normal control group (P < 0.01 respectively). There were 46 non-CVA patients, including 34 cases with UACS and 12 PIC, and their FeNO levels were not statistically different [(18.3 ± 7.6) to (19.2 ± 4.4) ppb, t = 2.580, P = 2.996]. The levels of FeNO declined rapidly in CVA patients after inhaled corticosteroids during the 4 week follow-up. The proportion of eosinophils in the sputum from CVA patients was higher than that from the non-CVA patients, consistent with the level of FeNO, which showed a positive linear correlation with sputum eosinophils. The area under ROC curve was 0.94.The optimal diagnostic cutoff point was 22.5 ppb which was capable of differentiating CVA and non-CVA with a sensitivity of 84%, and a specificity of 94.3%.
The level of FENO was higher in CVA compared to other causes of chronic cough. FeNO, a marker of airway eosinophilic inflammation, may be helpful in the diagnosis of CVA in children with high sensitivity and specificity.
确定呼出一氧化氮分数(FeNO)测定对儿童咳嗽变异性哮喘(CVA)诊断的价值。
纳入2012年3月至2013年4月在苏州大学附属儿童医院就诊的咳嗽超过4周的门诊患者。根据美国胸科学会指南,使用一氧化氮分析仪测量FeNO。比较CVA患者与其他慢性咳嗽病因患者的FeNO水平。通过绘制受试者工作特征(ROC)曲线评估FeNO的价值,并确定FeNO检测用于诊断CVA的最佳临界点。
共招募84例慢性咳嗽患儿,其中38例诊断为CVA。CVA患者[(37.2±13.8)ppb]与合并上气道咳嗽综合征(UACS)的CVA患者[(40.1±13.8)ppb,P = 0.124]的FeNO水平无统计学差异,但均显著高于UACS或感染后咳嗽(PIC)患者以及正常对照组(P均<0.01)。有46例非CVA患者,包括34例UACS患者和12例PIC患者,他们的FeNO水平无统计学差异[(18.3±7.6)至(19.2±4.4)ppb,t = 2.580,P = 2.996]。在4周的随访期间,吸入糖皮质激素后CVA患者的FeNO水平迅速下降。CVA患者痰液中的嗜酸性粒细胞比例高于非CVA患者,与FeNO水平一致,FeNO与痰液嗜酸性粒细胞呈正线性相关。ROC曲线下面积为0.94。最佳诊断临界点为22.5 ppb,能够区分CVA和非CVA,敏感性为84%,特异性为94.3%。
与其他慢性咳嗽病因相比,CVA患者的FENO水平更高。FeNO作为气道嗜酸性粒细胞炎症的标志物,可能有助于高灵敏度和特异性地诊断儿童CVA。